---
title: "Look AHEAD Study, Increased Plaque Progression & More: Your April Monthly Beat"
---

Findings from the LOOK AHEAD study indicated that dyslipidemia was associated with a higher risk of CVD outcomes in large samples...

| View in browser APRIL   Industry Updates JAHA Findings from the LOOK AHEAD study indicated that dyslipidemia was associated with a higher risk of CVD outcomes in large samples of obese individuals with T2DM   Diabetes Research Clinical Practice A recent retrospective cohort analysis examined the prevalence of retinopathy at T2DM diagnosis in real-world primary care settings   BioSpace European Commission (EC) has approved icosapent ethyl to reduce the risk of cardiovascular events in high-risk, statin-treated adult patients   Diabetes Care Analyses from DECLARE-TIMI 58 indicated that in patients with T2D and with multiple risk factors, dapagliflozin (SGLT2-i) reduced the risk of hospitalization for heart failure and adverse renal outcomes   European Heart Journal Recent PARADIGM substudy indicated that decline in renal function was associated with increased plaque progression, irrespective of the presence of CKD   JAMA Adding Strain Measure to LVEF Better Predicts Later HF     Coming Soon     Featured Recipe   New Podcast COVID-19 Disparities: Sneak Peek of Spring 2021 Keynote Keith C. Ferdinand, MD, FACC, FAHA Listen to CMHC's Senior Planning Committee Member and Spring 2021 Keynote, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, share his insights and clinical pearls regarding the disproportionate burden and disparities during the COVID-19 pandemic. Listen Now Also available on Apple Podcasts Spotify Youtube   Resource of the Month   Best Blog Read More           Cardiometabolic Health Congress, 1801 North Military, Suite 200, Boca Raton, Florida 33431, United States, 877.571.4700 Unsubscribe Manage preferences |
| --- |